Literature DB >> 9988853

Twelve-month outcome of patients with DSM-III-R schizoaffective disorder: comparisons to matched patients with bipolar disorder.

S M Strakowski1, P E Keck, K W Sax, S L McElroy, J M Hawkins.   

Abstract

Schizoaffective disorder is a relatively common illness with an uncertain relationship with bipolar disorder. The publication of DSM-III-R in 1987 operationalized the diagnosis of schizoaffective disorder, separating it from psychotic bipolar disorder by the presence of persistent psychosis in the absence of affective symptoms. Since that time, there have been few prospective outcome studies comparing schizoaffective and bipolar disorders. The authors recruited 27 hospitalized patients with schizoaffective disorder and compared their 12-month outcome to 27 sex-, age-, socioeconomic status- and race-matched hospitalized bipolar patients. The schizoaffective patients were significantly less likely to achieve syndromic recovery than the bipolar patients, although neither group achieved high rates of symptomatic or functional recovery. As expected, the schizoaffective patients were more likely to exhibit persistent psychosis, with or without affective symptoms, throughout the follow-up interval. These data provide clinical support of the predictive value of the DSM-III-R criteria for schizoaffective disorder in a naturalistic outcome setting.

Entities:  

Mesh:

Year:  1999        PMID: 9988853     DOI: 10.1016/s0920-9964(98)00119-4

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  4 in total

1.  The schizoaffective disorder diagnosis: a conundrum in the clinical setting.

Authors:  Jo Ellen Wilson; Hui Nian; Stephan Heckers
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-04-27       Impact factor: 5.270

Review 2.  Is schizoaffective disorder a useful diagnosis?

Authors:  Stephan Heckers
Journal:  Curr Psychiatry Rep       Date:  2009-08       Impact factor: 5.285

3.  The effects of centralised and specialised combined pharmacological and psychological intervention compared with decentralised and non-specialised treatment in the early course of severe unipolar and bipolar affective disorders--design of two randomised clinical trials.

Authors:  Lars Vedel Kessing; Hanne Vibe Hansen; Ellen Margrethe Christensen; Henrik Dam; Christian Gluud; Jørn Wetterslev
Journal:  Trials       Date:  2011-02-03       Impact factor: 2.279

4.  Psychotic symptoms in bipolar disorder and their impact on the illness: A systematic review.

Authors:  Subho Chakrabarti; Navdeep Singh
Journal:  World J Psychiatry       Date:  2022-09-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.